Mitigating the foreign body response (FBR) to implantable medical devices (IMDs) is critical
for successful long‐term clinical deployment. The FBR is an inevitable immunological …

Type 1 diabetes mellitus (T1DM) is a growing global health concern that affects
approximately 8.5 million individuals worldwide. T1DM is characterized by an autoimmune …

Wound healing remains a significant challenge worldwide, necessitating the development of
new wound dressings to aid in the healing process. This study presents a novel …

Extrusion-based bioprinting (EBB) holds potential for regenerative medicine. However, the
widely-used bioinks of EBB exhibit some limitations for skin regeneration, such as …

Pressure ulcers are areas of localized damage to the skin and underlying tissue, which
impose a major burden to patients and medical systems. Natural polymeric hydrogels …

Cellular therapies are poised to transform the field of medicine by restoring dysfunctional
tissues and treating various diseases in a dynamic manner not achievable by conventional …

Pancreatic islet transplantation efficacy for type 1 diabetes (T1D) management is limited by
hypoxia-related graft attrition and need for systemic immunosuppression. To overcome …

Autologous implantable scaffolds that induce vasculogenesis have shown great potential in
tissue regeneration; however, previous attempts mainly relied on cell‐laden hydrogel …

Successful therapeutic strategies for wound healing rely on proper vascularization while
inhibiting fibrosis. However, scaffolds designed for skin tissue engineering generally lack the …

Beta cell replacement has emerged as an attractive therapeutic alternative to traditional
exogenous insulin administration for management of type 1 diabetes (T1D). Beta cells …